Literature DB >> 4643395

Long-term effects of hydroxyurea in psoriases.

M G Dahl, J S Comaish.   

Abstract

Hydroxyurea is an effective treatment for psoriasis but consistently produces macrocytosis in peripheral blood with a fall in haemoglobin levels and white cell counts. In this long-term study of 16 patients anaemia and leukopenia have proved frequent and troublesome side effects requiring discontinuance of treatment in many cases. In view of these findings hydroxyurea cannot be recommended as the drug of first choice even for treating severe and intractable psoriasis, and it is our opinion that methotrexate is safer and at least as effective in these circumstances. The clearest indications for the use of hydroxyurea appear to be in life-ruining psoriasis when methotrexate treatment has either failed or is contraindicated because of liver damage. A great deal more investigative work is required before these indications can be generally extended.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4643395      PMCID: PMC1786814          DOI: 10.1136/bmj.4.5840.585

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  STUDY OF SERUM B12 AND FOLATE IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).

Authors:  W G THURMAN; W L WATKINS
Journal:  Cancer Chemother Rep       Date:  1964-08

2.  Hydroxyurea in the treatment of refractory psoriasis.

Authors:  J W Yarbro
Journal:  Lancet       Date:  1969-10-18       Impact factor: 79.321

Review 3.  Some hazards of methotrexate treatment of psoriasis.

Authors:  H Baker
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1970

4.  Hydroxyurea. A new treatment for psoriasis.

Authors:  U W Leavell; J W Yarbro
Journal:  Arch Dermatol       Date:  1970-08

5.  Comparison of cytotoxicity of hydroxyurea in normal and rapidly proliferating epidermis and small intestine in mice.

Authors:  H Hennings; F Devik
Journal:  Cancer Res       Date:  1971-03       Impact factor: 12.701

6.  The distribution, excretion and metabolism of hydroxyurea-C14.

Authors:  R H Adamson; S L Ague; S M Hess; J D Davidson
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

7.  Hydroxyurea in the treatment of pustular psoriasis.

Authors:  K M Stein; W B Shelley; R A Weinberg
Journal:  Br J Dermatol       Date:  1971-07       Impact factor: 9.302

8.  Hydroxyurea: a new antimetabolite in the treatment of psoriasis.

Authors:  M Rosten
Journal:  Br J Dermatol       Date:  1971-08       Impact factor: 9.302

9.  Hydroxyurea: effects on Chinese hamster cells grown in culture.

Authors:  W K Sinclair
Journal:  Cancer Res       Date:  1967-02       Impact factor: 12.701

10.  Liver damage due to methotrexate in patients with psoriasis.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1971-03-20
View more
  5 in total

1.  Reversible hyperpigmentation associated with high dose hydroxyurea.

Authors:  G Majumdar; S E Heard; N G Slater
Journal:  BMJ       Date:  1990-06-02

2.  Hydroxyurea for the Treatment of Psoriasis including in HIV-infected Individuals: A Review.

Authors:  Eric S Lee; Misha M Heller; Faranak Kamangar; Kelly Park; Wilson Liao; John Koo
Journal:  Psoriasis Forum       Date:  2011

Review 3.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Psoriasis: current concepts in management.

Authors:  L Hodge; J S Comaish
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

Review 5.  Hydroxyurea therapy for sickle cell anemia.

Authors:  Patrick T McGann; Russell E Ware
Journal:  Expert Opin Drug Saf       Date:  2015-09-14       Impact factor: 4.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.